Endlyz Therapeutics Inc. and Endlyz UK Ltd (together ‘Endlyz’) are developing disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias. By leveraging extensive industry experience, a robust investor syndicate, and academic collaborations that provide access to advanced technologies on an exclusive basis, Endlyz is well positioned to lead the industry in our programmes. The company is open to discuss collaborations and in-licensing of complimentary programmes. 

Endlyz Therapeutics

Org chart

Teams

Offices

Endlyz Therapeutics

Org chart

Teams

Offices

Related companies